CIK: 0001776382 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 16, 2021
Total Value ($000): $847,239 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALXO | ALX ONCOLOGY HLDGS INC | 9,699,925 | $530,392 | 62.6% | $39.31 | +52.2% | COM | 00166B105 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 3,504,624 | $98,936 | 11.7% | $36.46 | -17.7% | COM | 413197104 |
| — | AKERO THERAPEUTICS INC | 2,200,778 | $54,601 | 6.4% | $19.15 | — | COM | 00973Y108 |
| PHVS | PHARVARIS N V | 2,303,310 | $42,911 | 5.1% | $31.46 | -27.9% | COM | N69605108 |
| — | ELEVATION ONCOLOGY INC | 2,608,167 | $35,393 | 4.2% | $13.57 | — | COM | 28623U101 |
| APLS | APELLIS PHARMACEUTICALS INC | 411,471 | $26,005 | 3.1% | $15.34 | +236.3% | COM | 03753U106 |
| — | IMPEL NEUROPHARMA INC | 2,759,791 | $24,424 | 2.9% | $8.85 | — | COM | 45258K109 |
| — | CHECKMATE PHARMACEUTICALS IN | 3,673,374 | $21,893 | 2.6% | $11.51 | — | COM | 162818108 |
| — | METACRINE INC | 3,059,123 | $11,625 | 1.4% | $10.21 | — | COM | 59101E103 |
| — | VERONA PHARMA PLC | 161,897 | $1,059 | 0.1% | $9.65 | — | SPONSORED ADS | 925050106 |